Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

Trebicka, Jonel; Gu, Wenyi; Ibáñez-Samaniego, Luis; Hernández-Gea, Virginia; Pitarch, Carla; Garcia, Elisabet; Procopet, Bogdan; Giráldez, Álvaro; Amitrano, Lucio; Villanueva, Candid; Thabut, Dominique; Silva-Junior, Gilberto; Martinez, Javier; Genescà, Joan; Bureau, Cristophe; Llop, Elba; Laleman, Wim; Palazon, Jose Maria; Castellote, Jose; Rodrigues, Susanag; ... (2020). Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. Journal of hepatology, 73(5), pp. 1082-1091. Elsevier 10.1016/j.jhep.2020.04.024

[img]
Preview
Text
1-s2.0-S0168827820302361-main.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (785kB) | Preview

BACKGROUND & AIMS

The relationship between acute-on-chronic liver failure (ACLF) and acute variceal bleeding (AVB) is poorly understood. Specifically, the prevalence and prognosis of ACLF in the context of AVB is unclear, while the role of transjugular intrahepatic portosystemic shunt (TIPS) in the management in patients with ACLF has not been described to date.

METHODS

A multicenter, international, observational study was conducted in 2,138 patients from 34 centers between 2011 and 2015. ACLF was defined and graded according to the EASL-CLIF consortium definition. Placement of pre-emptive TIPS (pTIPS) was based on individual center policy. Patients were followed-up for 1 year, until death or liver transplantation. Cox regression and competing risk models (Gray's test) were used to identify independent predictors of rebleeding or mortality.

RESULTS

At admission, 380/2,138 (17.8%) patients had ACLF according to EASL-CLIF criteria (grade 1: 38.7%; grade 2: 39.2%; grade 3: 22.1%). The 42-day rebleeding (19% vs. 10%; p <0.001) and mortality (47% vs. 10%; p <0.001) rates were higher in patients with ACLF and increased with ACLF grades. Of note, the presence of ACLF was independently associated with rebleeding and mortality. pTIPS placement improved survival in patients with ACLF at 42 days and 1 year. This effect was also observed in propensity score matching analysis of 66 patients with ACLF, of whom 44 received pTIPs and 22 did not.

CONCLUSIONS

This large multicenter international real-life study identified ACLF at admission as an independent predictor of rebleeding and mortality in patients with AVB. Moreover, pTIPS was associated with improved survival in patients with ACLF and AVB.

LAY SUMMARY

Acute variceal bleeding is a deadly complication of liver cirrhosis that results from severe portal hypertension. This study demonstrates that the presence of acute-on-chronic liver failure (ACLF) is the strongest predictor of mortality in patients with acute variceal bleeding. Importantly, patients with ACLF and acute variceal (re)bleeding benefit from pre-emptive (early) placement of a transjugular intrahepatic portosystemic shunt.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology

UniBE Contributor:

Bosch, Jaime

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1600-0641

Publisher:

Elsevier

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

01 Dec 2020 17:28

Last Modified:

01 Dec 2020 17:28

Publisher DOI:

10.1016/j.jhep.2020.04.024

PubMed ID:

32339602

Uncontrolled Keywords:

Acute variceal bleeding Acute-on-chronic liver failure Cirrhosis Rebleeding

BORIS DOI:

10.7892/boris.148185

URI:

https://boris.unibe.ch/id/eprint/148185

Actions (login required)

Edit item Edit item
Provide Feedback